Exactech Announces Investor Presentation at Canaccord Genuity Growth Conference
<0> Exactech Inc.Investor contactsJody Phillips, 352-377-1140Chief Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins, 305-451-1888E-mail: </0>
(Nasdaq: ), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials will update investors at the 2012 Canaccord Genuity Growth Conference in Boston on Tuesday, August 14, 2012.
The presentation by Exactech president David Petty and CFO Jody Phillips will begin at 11:00 a.m. ET on Tuesday, August 14, followed by a question and answer session. The company will also host one-on-one meetings with investors during the conference.
Exactech’s investor presentation including updates from the second quarter 2012 will be available via live and archived webcast at and at
Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at . Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at and .
An investment profile on Exactech may be found at . To receive future releases in e-mail alerts, sign up at .